Both in Pharmaceuticals
Genelux vs PDS Biotechnology
Over the past year GNLX returned −54.9% and PDSB returned +19.5%; their daily moves had a correlation of 0.13.
GNLX −54.9% PDSB +19.5%Growth of $1, one year, split-adjusted
| Metric | GNLX | PDSB |
|---|---|---|
| Price | $2.42 | $1.13 |
| Market cap | $109.5M | $81.9M |
| Today | −2.42% | −13.08% |
| 1 month | −4.3% | +34.2% |
| 6 months | −13.3% | −13.7% |
| Year to date | −44.5% | +46.8% |
| 1 year | −55.5% | +15.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 13,686.7× | — |
| Net cash | $18.7M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 57.7% | 303.5% |
| Short % of float | 11.4% | 5.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).